Alpine Immune Sciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALPN and other ETFs, options, and stocks.About ALPN
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company, which focusses on discovering and developing innovative, protein-based immunotherapies to treat autoimmune and inflammatory diseases. Its product pipeline includes inflammatory diseases, immuno-oncology, and engineered cellular therapies.
CEOMitchell H. Gold
CEOMitchell H. Gold
Employees142
Employees142
HeadquartersSeattle, Washington
HeadquartersSeattle, Washington
Founded2007
Founded2007
Employees142
Employees142
ALPN Key Statistics
Market cap4.23B
Market cap4.23B
Price-Earnings ratio-93.34
Price-Earnings ratio-93.34
Dividend yield—
Dividend yield—
Average volume2.19M
Average volume2.19M
High today$64.65
High today$64.65
Low today$64.33
Low today$64.33
Open price$64.65
Open price$64.65
Volume1.39M
Volume1.39M
52 Week high$64.72
52 Week high$64.72
52 Week low$6.71
52 Week low$6.71
ALPN News
Yahoo Finance 1d
Earnings Preview: Alpine Immune Sciences, Inc. Q1 Earnings Expected to Decline - Yahoo FinanceThe market expects Alpine Immune Sciences, Inc. (ALPN) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter...
Analyst ratings
88%
of 8 ratingsBuy
12.5%
Hold
87.5%
Sell
0%